In cases of out-of-hospital sudden cardiac arrest, bystanders are now formally encouraged to bypass full cardiopulmonary resuscitation (CPR), in favor of continuous chest compressions. This instruction comes following a March 2008 scientific advisory published in the journal Circulation. Given that many bystanders are hesitant to intervene in these situations, citing fear that they will do more harm than good, wariness of infection risk, or other personal considerations, how can medical professionals motivate bystander participation? Dr. Michael Sayre, associate professor of emergency medicine at the Ohio State University College of Medicine and lead author of this advisory, considers our best strategies for increasing bystander participation, in accordance with the newest CPR guidelines. Dr. Mark Nolan Hill hosts.
Encouraging CPR Participation from Bystanders
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In cases of out-of-hospital sudden cardiac arrest, bystanders are now formally encouraged to bypass full cardiopulmonary resuscitation (CPR), in favor of continuous chest compressions. This instruction comes following a March 2008 scientific advisory published in the journal Circulation. Given that many bystanders are hesitant to intervene in these situations, citing fear that they will do more harm than good, wariness of infection risk, or other personal considerations, how can medical professionals motivate bystander participation? Dr. Michael Sayre, associate professor of emergency medicine at the Ohio State University College of Medicine and lead author of this advisory, considers our best strategies for increasing bystander participation, in accordance with the newest CPR guidelines. Dr. Mark Nolan Hill hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Updates From the 7th World Symposium Task Force
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
CETP inhibition: Lessons from two decades of clinical trials
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?